Charles River Labs in deal with AstraZeneca
Wilmington-based Charles River Laboratories International Inc. said it has entered into a deal with AstraZeneca PLC to perform early-stage experimental drug testing for the giant drug company before the products move to clinical trials. Charles River provides products and services to help pharmaceutical firms, government agencies, and academic institutions accelerate research and drug development efforts. Charles River said the three-year pact runs into 2015. Financial details weren’t disclosed.